Oral Liposomal Semaglutide
$350.00
or 4 interest-free installments by Afterpay.
Semaglutide is a Glucagon-Like peptide that mimic the hormone your gut naturally releases to tell your brain you’re full. It helps you eat less, feel fuller longer, lose weight, and improve the unhealthy amount of sugar and inflammation in your body
- Reduces emotional and binge eating
- Supports hormonal balance acting on more than 4 different hormones in the body
- Seen to improve A1c levels and slow the progression of prediabetes
- Enhances longevity & healthy aging due to inflammation reduction from weight loss 5. Clinical studies show 10-15% of body weight loss
Guaranteed safe checkout
Monday - Friday 9:00 - 17:00
Delivery Info
- Standard and Express delivery services are available for all items.
- Shipping costs are calculated at the checkout page (after delivery option & destination confirmation).
- Tracking is available for all delivery options.
- Items are delivered during standard business hours.
Description
Description
Semaglutide (Oral Liposomal)
Reset your hunger, metabolism, and energy with GLP-1 support
What it does:
Reduces hunger, improves glucose control, and supports fat loss. A gentle but powerful tool for weight and hormone balance.
Who it’s for:
- Patients seeking safe, effective body recomposition and metabolic healing.
- Busy adults struggling with plateaued weight loss
- Men with visceral fat (fat around the important organs in your body), fatigue, and insulin resistance of pre-diabetes
- Women with PCOS, perimenopause or slow metabolism
- Patients seeking long-term metabolic and anti-aging support
Form: Daily oral liposomal metered dose
Strength: 0.25mg–2.4mg (custom titration included)
Consultation Required: Yes
Bundle Options: Combine with NAD+, Metformin, or GHK-Cu for advanced protocols
Reviews (0)
Additional information
Additional information
| size | 0.25mg – 2.4mg |
|---|---|
| administration | Oral liposomal metered dose |
| dosage | Metered daily oral liposomal Semaglutide |
Reviews
There are no reviews yet.